Journal profile · GENETICS & HEREDITY
Genome Medicine
ISSN 1756-994X · BioMed Central · ENGLAND · Founded 2009
Genome Medicine: CAS Zone 1 · Biology (2025 upgraded edition, Top journal); impact factor 10.81; fully open access; APC about USD 5,490; median 226 days to acceptance (116 articles, last 24 months); 165 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Genome Medicine is published by BioMed Central and is in Zone 1 of Biology in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Genomics and Rare Diseases, Cancer Genomics and Diagnostics and Genetic Associations and Epidemiology, together about 34.9% of its articles. Its main subfields are Genetics and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Genome Medicine publishes outstanding research of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to, cancer genomics, immuno-oncology, immunogenomics, infectious disease, neurogenomics, cardiogenomics, clinical genomics, gene therapies, microbiome, systems medicine, precision medicine and clinical trials. The Journal welcomes submissions of original research, methodology, software and guideline articles as well as expert reviews and commentary across all areas of human health and disease.
From the journal's Aims & Scope
Research area (LetPub): GENETICS & HEREDITY
Editor-in-chief Rabia BegumPublisher website
Editorial board by country: 10 in mainland China (about 6%); most named United States 53, United Kingdom 21, Mainland China 10, Australia 10, Germany 9 (154 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology13.7%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology10.9%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology10.3%
- Single-cell and spatial transcriptomicsBiochemistry, Genetics and Molecular Biology6.2%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.5%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology5.1%
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology4.8%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 1 |
| Minor | Genetics & Heredity | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 1 |
| Minor | Genetics & Heredity | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 1 |
| Minor | Genetics & Heredity | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.81LetPub ·
- Impact factor (publisher) 2025
- 10.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 13.2Publisher website ·
- CiteScore 2026-06
- 18LetPub ·
- SJR 2026-06
- 4.97LetPub ·
- SNIP 2026-06
- 2.49LetPub ·
- h-index
- 66LetPub ·
- h-index
- 180OpenAlex ·
- i10-index
- 1,681OpenAlex ·
- 2-year mean citedness
- 10.95OpenAlex ·
- Self-citation rate
- 0.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 156LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 3,400,000Publisher website ·
Articles by year OpenAlex count · 2,317 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 182 | 182 | 144 |
| 2025 | 165 | 165 | 1,394 |
| 2024 | 154 | 154 | 3,950 |
| 2023 | 116 | 116 | 4,516 |
| 2022 | 147 | 147 | 9,159 |
| 2021 | 191 | 191 | 13,487 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
226 daysMedian, submission to acceptance · P25–P75 173 days – 280 days
- Acceptance to online
- median 15 days (116 articles)
- Submission to online
- median 248 days
- Sample
- 116 articles with submission and acceptance dates (382 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Submission to first decision
- 11 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 4,490 / USD 5,490 / GBP 3,690 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 5,290 / EUR 4,290 / GBP 3,590 | — | — | |
| LetPub | GBP 3,490 / USD 5,090 / EUR 4,090 | Yes | — | |
| Publisher website | GBP 3,690 / USD 5,490 / EUR 4,490 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
- Cancer evolutionDeadline
- Mental health and neuropsychiatric disordersDeadline
- MetastasisDeadline
Article types accepted10
- commentFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- databaseFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- guidelineFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- matters arisingFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- methodFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- perspectiveFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- researchFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- research highlightFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- reviewFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
- softwareFormatting guidelines for specific article types can be found below. Research Method Software Database Comment Research Highlight Review Perspective Guideline M…Length not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data availability: authors are encouraged or required to provide datasets, deposited in public repositories or included in the paper/supporting files; data availability statement required. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access licensing under CC BY-NC-ND or CC BY; authors retain copyright. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Genome Medicine articles are published open access under a CC BY-NC-ND (Creative Commons Attribution Non-Com…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2009
- ISSN
- 1756-994X
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Genome Medicine
What CAS zone is Genome Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Genome Medicine is in Zone 1 of Biology, and in Zone 1 of the minor category Genetics & Heredity; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Genome Medicine?
The latest impact factor listed by LetPub is 10.81; CiteScore 18, h-index 180.
How long does peer review take at Genome Medicine?
Based on the dates recorded on 116 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 226 days (interquartile range 173–280 days); authors report an average review time of 6–12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Genome Medicine based?
Of the 154 board members whose country the journal's board page names, 10 (about 6%) are in mainland China; the countries named most often are United States (53), United Kingdom (21) and Mainland China (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Genome Medicine?
According to LetPub and DOAJ records, Genome Medicine is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Genome Medicine open access, and what is the APC?
Genome Medicine is a fully open-access journal. APC about USD 5,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .